Related Experiment Videos
Structure-based design of novel, urea-containing FKBP12 inhibitors
P S Dragovich1, J E Barker, J French
1Agouron Pharmaceuticals, Inc., San Diego, California 92121, USA.
Journal of Medicinal Chemistry
|April 26, 1996
Abstract:
The structure-based design and subsequent chemical synthesis of novel, urea-containing FKBP12 inhibitors are described. These compounds are shown to disrupt the cis-trans peptidylprolyl isomerase activity of FKBP12 with inhibition constants (Ki,app) approaching 0.10 microM. Analyses of several X-ray crystal structures of FKBP12-urea complexes demonstrate that the urea-containing inhibitors associate with FKBP12 in a manner that is similar to, but significantly different from, that observed for the natural product FK506.